Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTHFD2 | P13995 | 14/20 | 0.59 |
| ▸ | MTHFD1 | P11586 | 10/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | ERN1 | O75460 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30038703 | 1.00 | MTHFD2 (0.59) | MTHFD2MTHFD1KDM4EHPGDHSD17B10 | |
| SCHEMBL21417117 | 1.00 | MTHFD2 (0.59) | MTHFD2MTHFD1KDM4EHPGDHSD17B10 | |
| SCHEMBL20208868 | 0.91 | MTHFD2 (0.60) | MTHFD2MTHFD1KDM4EHPGDHSD17B10 | |
| SCHEMBL20208671 | 0.90 | MTHFD2 (0.48) | MTHFD2MTHFD1KDM4EHPGDHSD17B10 | |
| SCHEMBL20208624 | 0.88 | MTHFD2 (0.62) | MTHFD2MTHFD1KDM4EHPGDHSD17B10 | |
| SCHEMBL30037861 | 0.88 | MTHFD2 (0.62) | MTHFD2MTHFD1KDM4EHPGDHSD17B10 | |
| SCHEMBL21354109 | 0.87 | MTHFD2 (0.64) | MTHFD2MTHFD1ERN1 | |
| SCHEMBL21354131 | 0.84 | MTHFD2 (0.51) | MTHFD2MTHFD1KDM4EHPGDHSD17B10 | |
| SCHEMBL30037740 | 0.84 | MTHFD2 (0.51) | MTHFD2MTHFD1KDM4EHPGDHSD17B10 | |
| SCHEMBL31535380 | 0.83 | MTHFD2 (0.50) | MTHFD2MTHFD1KDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3546463-B1 | SULFONAMIDE DERIVATIVE HAVING COUMARIN SKELETON | DAIICHI SANKYO CO LTD (JP) | 2022-12-07 | — | — | EP | disclosed |
| EP-3546463-B1 | SULFONAMIDE DERIVATIVE HAVING COUMARIN SKELETON | DAIICHI SANKYO CO LTD (JP) | 2022-12-07 | — | — | EP | disclosed |
| US-10774087-B2 | Sulfonamide derivative having coumarin skeleton | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2020-09-15 | — | — | US | disclosed |
| US-10774087-B2 | Sulfonamide derivative having coumarin skeleton | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2020-09-15 | — | — | US | disclosed |
| EP-3546463-A1 | SULFONAMIDE DERIVATIVE HAVING COUMARIN SKELETON | Daiichi Sankyo Co., Ltd. (JP) | 2019-10-02 | — | — | EP | disclosed |
| EP-3546463-A1 | SULFONAMIDE DERIVATIVE HAVING COUMARIN SKELETON | Daiichi Sankyo Co., Ltd. (JP) | 2019-10-02 | — | — | EP | disclosed |
| US-20190284198-A1 | SULFONAMIDE DERIVATIVE HAVING COUMARIN SKELETON | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2019-09-19 | — | — | US | disclosed |
| US-20190284198-A1 | SULFONAMIDE DERIVATIVE HAVING COUMARIN SKELETON | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2019-09-19 | — | — | US | disclosed |
| WO-2018097162-A1 | SULFONAMIDE DERIVATIVE HAVING COUMARIN SKELETON | 第一三共株式会社 | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284198-A1 | SULFONAMIDE DERIVATIVE HAVING COUMARIN SKELETON | MTHFD1, MTHFD2, DHFR | MTHFD2 2/4885MTHFD1 1/4885KDM4E 3782/4885 |
| US-10774087-B2 | Sulfonamide derivative having coumarin skeleton | MTHFD1, MTHFD2, DHFR | MTHFD2 2/4885MTHFD1 1/4885KDM4E 3782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.